Canadian Tobacco Company Urges Government for Harm Reduction Measures

Regulations by 2FIRSTS.ai
Jan.23.2024
Canadian Tobacco Company Urges Government for Harm Reduction Measures
Canadian tobacco company ITCAN urges government to adopt harm reduction approach to achieve smoking rate below 5% by 2035.

Canadian media outlet Muskoka411 reported on January 22nd that, as National Non-Smoking Week begins, Imperial Tobacco Canada (ITCAN) is urging the government and public health organizations to adopt harm reduction principles in order to achieve the goal of reducing smoking rates to below 5% by 2035.

 

Frank Silva, President and CEO of ITCAN, expressed that "harm reduction has proven effective in other industries, and we firmly believe it is the most effective way to reduce smoking rates in Canada." He added, "Governments and public health organizations can fulfill their responsibilities by actively supporting harm reduction and providing accessible solutions to Canadians."

 

ITCAN believes that through collective efforts, including industry, public health, and anti-smoking organizations, the stagnant smoking rates in Canada can be overcome. This requires the active participation of all relevant groups in open dialogues, for the benefit of public health, while also preventing biases against relatively lower-risk alternatives and addressing illegal products that may harm consumers.

 

Mr. Silva stated, "Despite having one of the world's most stringent regulations, the latest data from Statistics Canada shows that while there has been some progress, we still have a long way to go." He added, "We all recognize the health risks associated with smoking and agree that quitting is the best solution. Ensuring that adult smokers have access to accurate information and new, lower-risk alternatives to smoking is crucial in further reducing Canada's smoking rates."

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Launches National Priority Review Program: Drugs Aligned with U.S. Priorities May Be Approved in as Little as One Month
FDA Launches National Priority Review Program: Drugs Aligned with U.S. Priorities May Be Approved in as Little as One Month
The FDA has launched the Commissioner’s National Priority Voucher (CNPV) program, reducing the review time for certain drugs to as little as 1–2 months. While the program currently applies only to pharmaceuticals, it demonstrates the FDA’s capacity to reform its review pathways. Whether a similar mechanism could extend to tobacco products now appears to be a matter of timing and technical details.
Jun.18
Brazil Study: 11% of Teenagers Use E-Cigarettes, Consumption Rate Five Times Higher than Traditional Cigarettes
Brazil Study: 11% of Teenagers Use E-Cigarettes, Consumption Rate Five Times Higher than Traditional Cigarettes
A survey by the Federal University of São Paulo reveals 11% of teens (14+) use e-cigarettes, five times the rate of traditional cigarettes. Despite a ban, easy online access and higher nicotine content lead to misuse, reversing progress made by 1990s anti-smoking policies.
Jun.23 by 2FIRSTS.ai
Philip Morris International Expands Device Recycling Program, Plans to Repair One Million Heated Tobacco Devices by 2025
Philip Morris International Expands Device Recycling Program, Plans to Repair One Million Heated Tobacco Devices by 2025
PMI is actively promoting a circular economy, having successfully repaired around 867,000 heated tobacco devices to date. The company aims to reach one million repaired devices by 2025. Its Iluma series has seen notable success, with devices being recovered and reused, effectively reducing environmental impact.
Jul.24 by 2FIRSTS.ai
U.S. FDA Updates PMTA and SE Application Processes, Releases New Submission Forms and Validation Tools
U.S. FDA Updates PMTA and SE Application Processes, Releases New Submission Forms and Validation Tools
The U.S. FDA has released six new forms for submitting applications for new tobacco products, covering both the Premarket Tobacco Product Application (PMTA) and Substantial Equivalence (SE) pathways. Starting July 6, 2025, all applicants will be required to use the updated forms, as previous versions will no longer be accepted.
Jun.09 by 2FIRSTS.ai
Product | ELFBAR Launches JOINOne Series Featuring Magnetic Design and Adjustable Cooling
Product | ELFBAR Launches JOINOne Series Featuring Magnetic Design and Adjustable Cooling
ELFBAR has launched the JOINOne series, featuring two pod types—“Dock-to-Vape” and “Standalone Use”—with three-level cooling adjustment. The Dynamic and Lumeo devices offer three power modes. The series debuted at the 2025 Dubai Vape Expo and is now available on ELFBAR’s website.
Jul.24 by 2FIRSTS.ai
East Dongguan holds public hearing on illegal tobacco production case.
East Dongguan holds public hearing on illegal tobacco production case.
Tobacco Monopoly Administration announces public hearing on suspension of Dongguan tobacco company's business license.
Aug.05 by 2FIRSTS.ai